ArticleRegenerative therapy2020

Successful treatment of relapsed acute B-cell lymphoblastic leukemia with CD20/CD22 bispecific chimeric antigen receptor T-cell therapy.

Zuyu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.